For subscribers
Shortening the wait for infectious disease cures
Instead of getting antibodies from natural immune response, team engineers one on computer
Sign up now: Get ST's newsletters delivered to your inbox
(From left) Principal scientist Debbie Lee with a vial of Tyzivumab, assistant director Chionh Yok Hian with a multi-well plate demonstrating the effectiveness of Tyzivumab against the Zika virus, and laboratory manager Rasvinder Kaur with a flask of cells producing Tyzivumab antibodies. Tyzivumab was fit for clinical trials in just nine months.
ST PHOTO: LIM YAOHUI
Samantha Boh
An infectious disease spreads across countries, killing scores of people in months.
Meanwhile, scientists struggle to come up with a cure, hampered by a discovery and development process that takes years.
